A Study in Healthy Men to Test How Bosentan Influences the Amount of Zongertinib in the Blood
Clinical trial NCT07649941 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07649941
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-22
- Primary completion
- 2026-08-19
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.